These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 13628477)

  • 21. Experimental and clinical observations on 2,6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d) pyrimidine (Persantin).
    SOLOFF LA; GIMENEZ JL; WINTERS WL
    Am J Med Sci; 1962 Jun; 243():783-9. PubMed ID: 13914979
    [No Abstract]   [Full Text] [Related]  

  • 22. [Function and energy metabolism of the exhausted heart muscle under the effects of 2,6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d)-pyrimidine].
    SIESS M
    Arzneimittelforschung; 1962 Jul; 12():683-91. PubMed ID: 13912692
    [No Abstract]   [Full Text] [Related]  

  • 23. [Action of 2,6-bis(diethanolamino)-4,8-dipiperidino-pyrimido(5,4-d)pyrimidine on the dynamics of the isolated, spontaneously beating heart of warm-blooded animals].
    GEBHARDT W
    Arzneimittelforschung; 1961 Oct; 11():957-62. PubMed ID: 13897429
    [No Abstract]   [Full Text] [Related]  

  • 24. [The distribution of 2,6-bis (diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d)pyrimidine in organs and in the myocardial cells of rats and mice].
    KUNZ W; MUELLER E; SIESS M
    Arzneimittelforschung; 1963 Mar; 13():179-85. PubMed ID: 13927400
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect of 2,6-bis (diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d)-pyrimidine (Persantin) on the respiration of mitochondria in low O2 pressure].
    FRIMMER M; HEGNER D; WINKELMANN W
    Klin Wochenschr; 1963 Jul; 41():715-6. PubMed ID: 13959882
    [No Abstract]   [Full Text] [Related]  

  • 26. [BEHAVIOR OF CEREBRAL BLOOD FLOW AND METABOLISM AFTER ADMINISTRATION OF 2,6 BIS-(DIETHANOLAMINO)-4,8 DIPIPERIDINO-PYRIMIDO(5,4 D)-PYRIMIDINE].
    DELLAPORTA P; MAIOLO AT; ROSSELLA E
    Gazz Med Ital; 1963 Jul; 122():201-3. PubMed ID: 14047340
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of coronary insufficiency with high doses of pyrimido-pyrimidine].
    D'Anelli A
    Minerva Cardioangiol; 1970 Feb; 18(2):141-6. PubMed ID: 5446673
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effect of 2,6-bis(diethanolamino)-4, 8-dipiperidino-pyrimidino-(5,4-d)pyrimidine and of the glucuronide of this substance on blood pressure, metabolite content of the blood, liver and myocardium].
    THORN W; JACOBS G; SCHOLL H; MUELDENER B; WUPPERMANN M
    Arzneimittelforschung; 1962 Jun; 12():606-14. PubMed ID: 13921020
    [No Abstract]   [Full Text] [Related]  

  • 29. [The effect of a new coronary dilating substance: 2, 6-diethylamino)4, 8-dipiperidino-pyrimido(5, 4-d)pyrimidine].
    PABST HW
    Med Klin; 1959 Feb; 54(7):257-60. PubMed ID: 13643560
    [No Abstract]   [Full Text] [Related]  

  • 30. [Ultrastructural studies of the myocardium of animals treated with 2,6-bis-diethanol-amino-4,8-dipiperidino-pyrimido-5,4-pyrimidine].
    Sirigu F; Demurtas A; Pellegrini A
    Minerva Cardioangiol; 1967 Jul; 15(7):448-51. PubMed ID: 5615126
    [No Abstract]   [Full Text] [Related]  

  • 31. [Solubilization of 2,6-bis-(diethanolamino)-4,8-dipiperidinio-pyrimido (5,4-D)-pyrimidine].
    AUDISIO G
    G Med Mil; 1962; 113():202-8. PubMed ID: 13965477
    [No Abstract]   [Full Text] [Related]  

  • 32. [Studies on the effect of 2,6-bis(dethanolamino)-4, 8-dipiperidino-pyrimido(5,4-d) pyrimidine on myocardial metabolism].
    KUNZ W; SCHMID W; SIESS M
    Arzneimittelforschung; 1962 Nov; 12():1098-109. PubMed ID: 13927401
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies on the syntheses of sulfur containing pyrimido [5,4-d]pyrimidine derivatives. IV. The mechanism of dipyridamole formation from 4,8-dipiperidino-pyrimido [5,4-d]pyrimidine-2,6-disulfonyl dichloride and diethanolamine].
    Imai K; Kojima T; Tamazawa K; Takahashi K; Kawahara S
    Yakugaku Zasshi; 1976 May; 96(5):600-7. PubMed ID: 987191
    [No Abstract]   [Full Text] [Related]  

  • 34. [FLUORIMETRIC DETERMINATION OF 2,6-BIS(DI(2-HYDROXYETHYL)AMINO)-4, 8-DIPIPERIDINO-PYRIMIDO(5,4-D)PYRIMIDINE IN PLASMA AND ERYTHROCYTES].
    LABADIE P
    Pathol Biol; 1964 Jan; 12():24-31. PubMed ID: 14133422
    [No Abstract]   [Full Text] [Related]  

  • 35. [The elimination of adenosine from the blood under the influence of 2,6-bis(diethanolamino)-4,8-dipiperidinopyrimido-(5,4-d) pyrimidine and papaverine].
    KOSS FW; BEISENHERZ G; MAERKISCH R
    Arzneimittelforschung; 1962 Nov; 12():1130-1. PubMed ID: 14035013
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacological influencing of coronary blood flow after acute experimental obstruction].
    SZABO G; MAGYAR S; SOLTI F
    Z Kreislaufforsch; 1958 Nov; 47(21-22):971-82. PubMed ID: 13625843
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiaccelerator, coronary dilator and certain other pharmacologic actions of new poly-methoxyphenyl derivatives.
    KARCZMAR AG; BOURGAULT P; ELPERN B
    Proc Soc Exp Biol Med; 1958 May; 98(1):114-8. PubMed ID: 13554559
    [No Abstract]   [Full Text] [Related]  

  • 38. The synthesis and antibacterial activity of 3-alkyl derivatives of some pyrimido[4,5-d] pyrimidine.
    Cieplik J; Pluta J; Gubrynowicz O
    Acta Pol Pharm; 2003; 60(6):487-92. PubMed ID: 15080598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxic and pharmacological preconditioning preserves vasomotor response of porcine coronary artery.
    Kuzner J; Drevensek G; Gersak B; Budihna M
    Pol J Pharmacol; 2004; 56(6):789-97. PubMed ID: 15662092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the relaxant response to N,N'-dipropyl-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine in porcine coronary arteries.
    Moritz A; Gust R; Pertz HH
    J Pharmacol Exp Ther; 2007 May; 321(2):699-706. PubMed ID: 17322023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.